| |
|
|
CAMBRIDGE, MASS. - Biotech company Alkermes, partnering with pharmaceutical companies to develop their drugs, is expanding in Cambridge with 150,000 sf dedicated to new labs and offices. A 90,000-sf manufacturing facility is being renovated in Chelsea, Mass., by Alkermes for the production of GlaxoSmithKline’s inhalable insulin, and a new plant to manufacture a drug for Johnson & Johnson is being built in Wilmington, Ohio.
|
|
 |
Would you like information like this delivered to your email inbox? Subscribe to Tradeline Updates to keep abreast of the latest conference developments, industry news, best practices and more! Sign Up Now!
|
|
Printer Friendly Version
Send to a Friend
